An Investigation of the Stability of Free and Glucuronidated 11-Nor-Δ9-Tetrahydrocannabinol-9-carboxylic Acid in Authentic Urine Samples

Journal of Analytical Toxicology

Volumn 28, Issue 1, 2004, Pages 35-40

  Skopp, Gisela ^a,c   Pötsch, Lucia ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Institute of Legal Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; TETRAHYDROCANNABINOLIC ACID;

ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; FORENSIC MEDICINE; GLUCURONIDATION; HUMAN; LIQUID CHROMATOGRAPHY; PH; TANDEM MASS SPECTROMETRY; URINALYSIS;

CANNABIS;

EID: 1642458210     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.1.35     Document Type: Article

References (25)

1. B. Law, P.A. Mason, A.C. Moffat, R.I. Gleadle, and L.J. King. Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin. J. Pharm. Pharmacol. 36: 289-294 (1984).
2. G. Skopp, L. Pötsch, B. Ganssmann, M. Mauden, B. Richter, R. Aderjan, and R. Mattern. Freie und glucuronidierte cannabinoide im urin-untersuchungen zur einschätzung des konsumverhaltens. Rechtsmed 10: 21-28 (1999).
3. S. Agurell, M. Halldin, J.E. Lindgren, A. Ohlsson, M. Widman, H. Gillespie, and L. Hollister. Pharmacokinetics and metabolism of Δ1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol. Rev. 38: 21-43 (1986).
4. 9-tetrahydrocannabinol-11-oic acid glucuronide: a tetrahydrocannabinol metabolite. J. Pharm. Pharmacol. 32: 445-448 (1980).
5. P. Kelly and R.T. Jones. Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. J. Anal. Toxicol. 16: 228-235 (1992).
6. B.C. Sallustio, L. Sabordo, A.M. Evans, and R.L. Nation. Hepatic disposition of electrophilic acyl glucuronide conjugates. Curr. Drug Metab. 1: 163-180 (2000).
7. 9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J. Anal. Toxicol. 23: 323-332 (1999).
8. S. Dugan, S. Bogema, R.W. Schwartz, and N.T. Lappas. Stability of drugs of abuse in urine samples stored at -20°C. J. Anal. Toxicol. 18: 391-396 (1994).
9. G. Anderson and M. Scott. Determination of product shelf life and activation energy for five drugs of abuse. Clin. Chem. 37: 398-402 (1991).
10. 9-THC-9-carboxylic acid. J. Anal. Toxicol. 20: 291-300 (1996).
11. D.E. Moody, K.M. Monti, and A.C. Spanbauer. Long-term stability of abused drugs and antiabuse chemotherapeutical agents stored at -20°C. J. Anal. Toxicol. 23: 535-540 (1999).
12. B.D. Paul, R.M. McKinley, J.K. Walsh, T.S. Jamir, and M.R. Past. Effect of freezing on the concentration of drugs of abuse in urine. J. Anal. Toxicol. 17: 378-380 (1993).
13. R.W. Romberg and M.R. Past. Reanalysis of forensic urine specimens containing benzoylecgonine and THC-COOH. J. Forensic Sci. 39: 479-485 (1994).
14. M.E. Alburges and M.A. Peat. Profiles of delta-9-tetrahydrocannabinol metabolites in urine of marijuana users: preliminary observations by high performance liquid chromatographyradioimmunoassay. J. Forensic Sci. 31: 695-706 (1986).
15. 9-tetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography-tandem mass spectrometry. Clin. Chem. 48: 301-303 (2002).
16. B. Levine and M.L. Smith. Stability of drugs of abuse in biological specimens. Forensic Sci. Rev. 2: 147-157 (1990).
17. S. Golding Fraga, J.F. Diaz-Flores Estevez, and C. Diaz Romero. Stability of cannabinoids in urine in three storage temperatures. Ann. Clin. Lab. Sci. 28: 160-162 (1998).
18. W.G. Guder. Niere und ableitende Harnwege. In Lehrbuch der Klinischen Chemie und Pathobiochemie, H. Greiling and A.M. Gressner, Eds. Schattauer, New York, NY, 1995, pp 743-744.
19. D. Stamm. A new concept for quality control of clinical laboratory investigations in the light of clinical requirements and based on reference method values. J. Clin. Chem. Clin. Biochem. 20: 817-824 (1982).
20. 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS. J. Anal. Toxicol. 19: 285-291 (1995).
21. T. Dextraze, W.C. Griffiths, P. Camara, L. Audette, and M. Rosner. Comparison of fluorescence polarization immunoassay, enzyme immunoassay and thin-layer chromatography for urine cannabinoid screening: effects of analyte adsorption and vigorous mixing of specimen on detectability. Ann. Clin. Lab. Sci. 19: 133-138 (1989).
22. W.A. Joern. Surface adsorption of the urinary marijuana carboxy metabolite: the problem and a partial solution. J. Anal. Toxicol. 16: 401 (1992).
23. 9-carboxy tetrahydrocannabinol glucuronide. Forensic Sci. Int. 126: 17-23 (2002).
24. L.W. Robertson, S.W. Koch, S.R. Huff, R.K. Malhotra, and A. Gosh. Microbiological oxidation of the pentyl side chain of cannabinoids. Experientia 34: 1020-1022 (1978).
25. S.W. Toennes and G.F. Kauert. Importance of Vacutainer selection in forensic toxicological analysis of drugs of abuse. J. Anal. Toxicol. 25: 339-343 (2001).